EQIX
59
2
NWSA
75
8
PLD
40
2
SYY
41
2
ICE
55
2
HST
57
4
PNW
57
4
GOOG
83
4
TROW
48
6
ADI
59
2
PDCO
77
2
KO
46
4
BK
61
3
PPG
60
3
TGNA
50
2
GOOGL
66
2
AXP
67
4
THC
53
3
GM
61
4
CTAS
42
2
EQIX
59
2
NWSA
75
8
PLD
40
2
SYY
41
2
ICE
55
2
HST
57
4
PNW
57
4
GOOG
83
4
TROW
48
6
ADI
59
2
PDCO
77
2
KO
46
4
BK
61
3
PPG
60
3
TGNA
50
2
GOOGL
66
2
AXP
67
4
THC
53
3
GM
61
4
CTAS
42
2
Financhill
Back

SPDR S&P Pharmaceuticals ETF Stock Predictions

FREE REPORT: 2025 Gold Price Outlook

Get Your Copy of "2025 Gold Forecast: A Perfect Storm for Demand" Here.
Sell
45

XPH
SPDR S&P Pharmaceuticals ETF

Last Price:
$43.60
Seasonality Move:
0.25%

7 Day Trial

ALL ACCESS PASS

$ 7

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

SPDR S&P Pharmaceuticals ETF Stock Forecast

  • Over the next 52 weeks, SPDR S&P Pharmaceuticals ETF has on average historically risen by 7% based on the past 18 years of stock performance.
  • SPDR S&P Pharmaceuticals ETF has risen higher in 10 of those 18 years over the subsequent 52-week period, corresponding to a historical accuracy of 55.56%
  • Is SPDR S&P Pharmaceuticals ETF Stock Undervalued?
    The current SPDR S&P Pharmaceuticals ETF [XPH] share price is $43.41. The Score for XPH is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
  • XPH is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will SPDR S&P Pharmaceuticals ETF Stock Go Up Next Year?

  • Over the next 52 weeks, SPDR S&P Pharmaceuticals ETF has on average historically risen by 7% based on the past 18 years of stock performance.

SPDR S&P Pharmaceuticals ETF Stock Rating

Sell
45
SPDR S&P Pharmaceuticals ETF (XPH) is a Sell

Is SPDR S&P Pharmaceuticals ETF overpriced?

  • SPDR S&P Pharmaceuticals ETF has risen higher in 10 of those 18 years over the subsequent 52-week period, corresponding to a historical accuracy of 55.56%

SPDR S&P Pharmaceuticals ETF Stock Price History

Is XPH stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and XPH is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NYSEARCA
Country:
United States
Industry:
Sector:
Type:
etf
Website:

52-Week Data

52-Week High:
48.76
52-Week Low:
38.88

Prediction Charts

Market Cap:
0
Price in USD:
43.41
Volume:
86.6K
Beta:
0.80

Technical Analysis

SMA50:
45.91
SMA100:
44.79
SMA200:
42.92
52-Wk Change:
5.83%

Stock Predictions

  • Is SPDR S&P Pharmaceuticals ETF stock public?
    Yes, SPDR S&P Pharmaceuticals ETF is a publicly traded company.
  • What is the SPDR S&P Pharmaceuticals ETF stock quote today?
    The SPDR S&P Pharmaceuticals ETF stock price is 43.41 USD today.
  • How to buy SPDR S&P Pharmaceuticals ETF stock online?
    You can buy SPDR S&P Pharmaceuticals ETF shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Dec-4 45.78 46.02 46.10 45.77
Dec-5 45.65 45.59 45.89 45.46
Dec-6 45.82 46.12 46.15 45.82
Dec-9 46.21 45.77 46.25 45.66
Dec-10 45.48 45.32 45.73 45.19
Dec-11 45.26 45.28 45.49 44.91
Dec-12 45.35 44.54 45.35 44.51
Dec-13 44.44 44.05 44.44 43.95
Dec-16 44.16 44.34 44.82 44.03
Dec-17 44.61 44.66 44.85 44.32
Dec-18 44.68 43.49 44.87 43.19
Dec-19 43.74 43.25 43.88 42.97
Dec-20 43.19 43.42 43.97 43.07
Dec-24 43.42 43.41 43.47 43.08

SPDR S&P Pharmaceuticals ETF Earnings

Data Unavailable

SPDR S&P Pharmaceuticals ETF Forecast Revenue Growth

Data Unavailable

* SPDR S&P Pharmaceuticals ETF stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.